These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 11027594

  • 1. Antigenicity of chimeric synthetic peptides based on HTLV-1 antigens and the impact of epitope orientation.
    Hernández M, Selles ME, Pozo Peña L, Gómez I, Melchor A.
    Biochem Biophys Res Commun; 2000 Oct 05; 276(3):1085-8. PubMed ID: 11027594
    [Abstract] [Full Text] [Related]

  • 2. Chimeric synthetic peptides from the envelope (gp46) and the transmembrane (gp21) glycoproteins for the detection of antibodies to human T-cell leukemia virus type II.
    Hernández Marin M, Castellanos Pentón P, Márquez Bocalandro Y, Pozo Peña L, Díaz Navarro J, González López LJ.
    Biochem Biophys Res Commun; 2001 Nov 23; 289(1):7-12. PubMed ID: 11708768
    [Abstract] [Full Text] [Related]

  • 3. Chimeric synthetic peptides containing two immunodominant epitopes from the envelope gp46 and the transmembrane gp21 glycoproteins of HTLV-I virus.
    Hernández Marin M, Castellanos Pentón P, Márquez Bocalandro Y, Pozo Peña L, Díaz Navarro J, González López LJ.
    Biochem Biophys Res Commun; 2001 Nov 23; 289(1):1-6. PubMed ID: 11708767
    [Abstract] [Full Text] [Related]

  • 4. Study of the peptide length and amino acid specific substitution in the antigenic activity of the chimeric synthetic peptides, containing the p19 core and gp46 envelope proteins of the HTLV-I virus.
    Marin MH, Rodríguez-Tanty C, Higginson-Clarke D, Bocalandro YM, Peña LP.
    Biochem Biophys Res Commun; 2005 Oct 28; 336(3):983-6. PubMed ID: 16157308
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immunogenicity and conformational properties of an N-linked glycosylated peptide epitope of human T-lymphotropic virus type 1 (HTLV-I).
    Conrad SF, Byeon IJ, DiGeorge AM, Lairmore MD, Tsai MD, Kaumaya PT.
    Biomed Pept Proteins Nucleic Acids; 1995 Oct 28; 1(2):83-92. PubMed ID: 9346859
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
    Palker TJ, Tanner ME, Scearce RM, Streilein RD, Clark ME, Haynes BF.
    J Immunol; 1989 Feb 01; 142(3):971-8. PubMed ID: 2563272
    [Abstract] [Full Text] [Related]

  • 9. Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.
    Baba E, Nakamura M, Tanaka Y, Kuroki M, Itoyama Y, Nakano S, Niho Y.
    J Immunol; 1993 Jul 15; 151(2):1013-24. PubMed ID: 7687611
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of immunodominant epitopes of human T-lymphotropic virus type 1 (HTLV-I) using synthetic peptides.
    Lairmore MD, Lal RB, Kaumaya PT.
    Biomed Pept Proteins Nucleic Acids; 1995 Jul 15; 1(3):117-22. PubMed ID: 9346842
    [Abstract] [Full Text] [Related]

  • 11. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.
    Baba E, Nakamura M, Ohkuma K, Kira J, Tanaka Y, Nakano S, Niho Y.
    J Immunol; 1995 Jan 01; 154(1):399-412. PubMed ID: 7527817
    [Abstract] [Full Text] [Related]

  • 12. Influence of amino acid substitutions on antigenicity of immunodominant regions of the HTLV type I envelope surface gylcoprotein: a study using monoclonal antibodies raised against relevant peptides.
    Londos-Gagliardi D, Jauvin V, Armengaut MH, Astier-Gin T, Goetz M, Huet S, Guillemain BJ.
    AIDS Res Hum Retroviruses; 1999 Jul 01; 15(10):909-20. PubMed ID: 10408728
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Identification of immunoreactive epitopes in proteins coded by gag, env, and pol genes of the type I human T-lymphotropic virus (HTLV-I) using synthetic peptides].
    Iaroslavtseva NG, Ivanov VS, Grebennikova ZhO, Kornilaeva GV, Pashkova TA, Chikin LD, Ostrovskiĭ AG, Andreev SM, Khaitov RM, Karamov EV.
    Bioorg Khim; 1995 Oct 01; 21(10):752-60. PubMed ID: 8573207
    [Abstract] [Full Text] [Related]

  • 16. Chimeric synthetic peptides from the nucleocapsid p24 protein of human immunodeficiency virus type-1.
    Hernández M, Rodríguez I, Pozo L, Rivero J.
    Biochem Biophys Res Commun; 2001 Mar 23; 282(1):1-3. PubMed ID: 11263961
    [Abstract] [Full Text] [Related]

  • 17. [Immunoreactivity of synthetic peptides, corresponding to B-cellular epitopes of human type I T-lymphotrophic virus structural proteins].
    Rasuli AM, Klepikov NN, Andreev SM, Sidorova MV, Vafina MG, Seniuta NB, Pavlish OA, Syrtsev AV, Gurtsevich VE.
    Mol Biol (Mosk); 1993 Mar 23; 27(4):880-7. PubMed ID: 8361494
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.